| SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study A Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ... Thorax 75 (12), 1089-1094, 2020 | 279 | 2020 |
| Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine RP Payne, S Longet, JA Austin, DT Skelly, W Dejnirattisai, S Adele, ... Cell 184 (23), 5699-5714. e11, 2021 | 267 | 2021 |
| Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia H Parry, G McIlroy, R Bruton, M Ali, C Stephens, S Damery, A Otter, ... Blood cancer journal 11 (7), 136, 2021 | 120 | 2021 |
| Sensitive detection of SARS-CoV-2–specific antibodies in dried blood spot samples GL Morley, S Taylor, S Jossi, M Perez-Toledo, SE Faustini, ... Emerging infectious diseases 26 (12), 2970, 2020 | 81 | 2020 |
| Subclinical Reactivation of Cytomegalovirus Drives CD4+CD28null T-Cell Expansion and Impaired Immune Response to Pneumococcal Vaccination in … D Chanouzas, M Sagmeister, S Faustini, P Nightingale, A Richter, ... The Journal of infectious diseases 219 (2), 234-244, 2019 | 81 | 2019 |
| Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial … DA Jolliffe, H Holt, M Greenig, M Talaei, N Perdek, P Pfeffer, G Vivaldi, ... bmj 378, 2022 | 75 | 2022 |
| Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection AG Richter, AM Shields, A Karim, D Birch, SE Faustini, L Steadman, ... Clinical & Experimental Immunology 205 (2), 99-105, 2021 | 66 | 2021 |
| COVID-19: seroprevalence and vaccine responses in UK dental care professionals AM Shields, SE Faustini, CA Kristunas, AM Cook, C Backhouse, L Dunbar, ... Journal of dental research 100 (11), 1220-1227, 2021 | 60 | 2021 |
| Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection SE Faustini, SE Jossi, M Perez-Toledo, AM Shields, JD Allen, ... MedRxiv, 2020 | 60 | 2020 |
| Validation of a combined ELISA to detect IgG, IgA and IgM antibody responses to SARS-CoV-2 in mild or moderate non-hospitalised patients AM Cook, SE Faustini, LJ Williams, AF Cunningham, MT Drayson, ... Journal of immunological methods 494, 113046, 2021 | 51 | 2021 |
| Serology confirms SARS-CoV-2 infection in PCR-negative children presenting with paediatric inflammatory multi-system syndrome M Perez-Toledo, SE Faustini, SE Jossi, AM Shields, ... MedRxiv, 2020 | 50 | 2020 |
| Vitamin D status and seroconversion for COVID-19 in UK healthcare workers AA Faniyi, ST Lugg, SE Faustini, C Webster, JE Duffy, M Hewison, ... European Respiratory Journal 57 (4), 2021 | 48 | 2021 |
| SARS-CoV-2 seroconversion in health care workers AM Shields, SE Faustini, M Perez-Toledo, S Jossi, E Aldera, JD Allen, ... MedRxiv, 2020.05. 18.20105197, 2020 | 48 | 2020 |
| Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response AM Shields, SE Faustini, M Perez-Toledo, S Jossi, JD Allen, S Al-Taei, ... BMJ open respiratory research 8 (1), e000872, 2021 | 46 | 2021 |
| SARS-CoV-2 vaccine responses in individuals with antibody deficiency: findings from the COV-AD study AM Shields, SE Faustini, HJ Hill, S Al-Taei, C Tanner, F Ashford, ... Journal of clinical immunology 42 (5), 923-934, 2022 | 45 | 2022 |
| Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis H Parry, R Bruton, G Tut, M Ali, C Stephens, D Greenwood, S Faustini, ... The Lancet Healthy Longevity 2 (9), e554-e560, 2021 | 44 | 2021 |
| Namilumab or infliximab compared with standard of care in hospitalised patients with COVID-19 (CATALYST): a randomised, multicentre, multi-arm, multistage, open-label, adaptive … BA Fisher, T Veenith, D Slade, C Gaskell, M Rowland, T Whitehouse, ... The Lancet Respiratory Medicine 10 (3), 255-266, 2022 | 41 | 2022 |
| Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK) M Talaei, S Faustini, H Holt, DA Jolliffe, G Vivaldi, M Greenig, N Perdek, ... BMC medicine 20 (1), 87, 2022 | 41 | 2022 |
| Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine JA Herbert, EJ Kay, SE Faustini, A Richter, S Abouelhadid, J Cuccui, ... Vaccine 36 (26), 3809-3819, 2018 | 36 | 2018 |
| Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia H Parry, G McIlroy, R Bruton, S Damery, G Tyson, N Logan, C Davis, ... Journal of hematology & oncology 15, 1-12, 2022 | 34 | 2022 |
